Differential hydrogen sulfide production by a human cohort in response to animal- and plant-based diet interventions-Reference-Cited by-同舟云学术

Differential hydrogen sulfide production by a human cohort in response to animal- and plant-based diet interventions

Published:2022-06 Issue:6 Volume:41 Page:1153-1162
ISSN:0261-5614
Container-title:Clinical Nutrition
language:en
Short-container-title:Clinical Nutrition

Author:

Teigen Levi^ORCID,Mathai Prince P.,Lopez Sharon,Matson Michael,Elkin Baila^ORCID,Kozysa Daria^ORCID,Kabage Amanda J.,Hamilton Matthew,Vaughn Byron P.,Sadowsky Michael J.,Khoruts Alexander^ORCID

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine,Nutrition and Dietetics

Reference43 articles.

1. Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men;Nguyen;Gastroenterology,2020

2. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis;Rowan;Br J Surg,2009

3. Influence of short-term changes in dietary sulfur on the relative abundances of intestinal sulfate-reducing bacteria;Dostal Webster;Gut Microbes,2019

4. Fecal hydrogen sulfide production in ulcerative colitis;Levine;Am J Gastroenterol,1998

5. Modulation of colonic hydrogen sulfide production by diet and mesalazine utilizing a novel gas-profiling technology;Yao;Gut Microbes,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of Common Sulfur-Containing Substrates to Hydrogen Sulfide Production By Human Gut Microbiota Using an In Vitro Model Standardized For Bacterial Counts;Gut Microbes Reports;2024-06-27

2. Altered gut microbial functional pathways in people with Irritable Bowel Syndrome enable precision health insights;2024-02-16

3. Hydrogen Sulfide and Liver Health: Insights into Liver Diseases;Antioxidants & Redox Signaling;2024-01-01

4. The sulfur microbial diet and increased risk of obesity: Findings from a population-based prospective cohort study;Clinical Nutrition;2023-05

5. Gaseous metabolites as therapeutic targets in ulcerative colitis;World Journal of Gastroenterology;2023-01-28